Mips Logo

Mips

Licenses patented helmet technology to reduce rotational impact injuries in sports and construction.

MIPS | ST

Overview

Corporate Details

ISIN(s):
SE0009216278 (+4 more)
LEI:
549300LZSA4S0L54VQ25
Country:
Sweden
Address:
Kemistvägen 1B, 183 79 TÄBY
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Mips is a developer of helmet-based safety technology focused on reducing head injuries. Its core product is the Mips® Safety System (Multi-Directional Impact Protection System), a patented Brain Protection System (BPS). Born from scientific research by a brain surgeon and a biomechanics scientist, the system incorporates a low-friction layer inside helmets. This layer is designed to move slightly upon an angled impact, helping to redirect harmful rotational motion away from the head and potentially reducing the risk of certain brain injuries. Mips licenses its technology to numerous helmet manufacturers for use in products across a wide range of markets, including cycling, snow sports, motorcycling, equestrian, and construction.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-22 07:30
Quarterly Report
Swedish 2.2 MB
2025-10-22 07:30
Quarterly Report
English 2.2 MB
2025-07-16 07:30
Earnings Release
Swedish 1.9 MB
2025-07-16 07:30
Earnings Release
English 1.9 MB
2025-05-07 11:45
AGM Information
Kommuniké från årsstämman i Mips AB (publ) den 7 maj 2025
Swedish 36.0 KB
2025-05-07 11:45
AGM Information
Press release from the Annual General Meeting in Mips AB (publ) on 7 May 2025
English 33.4 KB
2025-04-24 07:30
Quarterly Report
Swedish 1.2 MB
2025-04-24 07:30
Quarterly Report
English 1.2 MB
2025-03-20 17:20
Annual Report (ESEF)
Swedish 2.5 MB
2025-02-05 18:10
Earnings Release
Mips updates long-term financial target
English 39.4 KB
2025-02-05 18:10
Report Publication Announcement
Mips uppdaterar långsiktigt finansiellt mål
Swedish 39.3 KB
2025-02-05 18:10
Earnings Release
Swedish 3.0 MB
2025-02-05 18:10
Annual Report
English 3.0 MB
2024-10-24 07:30
Quarterly Report
Swedish 1.3 MB
2024-10-24 07:30
Interim / Quarterly Report
English 1.4 MB

Automate Your Workflow. Get a real-time feed of all Mips filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Mips

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Mips via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-10-25 Thomas Bräutigam Other Sell 4,500 2,430,000.00 SEK
2023-09-14 John Fredrik Kjellberg Other Sell 10,300 3,705,837.00 SEK
2023-03-03 Maria Hedengren Other Buy 200 98,254.00 SEK
2022-10-18 Thomas Bräutigam Other Buy 2,000 609,594.40 SEK
2022-10-17 Thomas Bräutigam Other Buy 3,000 907,927.80 SEK
2022-05-06 Thomas Bräutigam Other Buy 1,000 580,600.00 SEK
2022-05-05 Thomas Bräutigam Other Buy 2,000 1,253,200.00 SEK
2022-03-07 Jonas Rahmn Other Buy 107 75,301.25 SEK
2022-03-07 Jonas Rahmn Other Buy 94 66,317.00 SEK
2022-03-07 Jonas Rahmn Other Buy 90 63,495.00 SEK

Peer Companies

Ceres Power Holdings PLC Logo
Licensing solid oxide tech (SOFC/SOEC) for clean power and green hydrogen to global partners.
United Kingdom
CWR
Certara, Inc. Logo
Accelerating new medicines with biosimulation software and services for pharma & biotech.
United States of America
CERT
CervoMed Inc. Logo
Developing CNS therapeutics for neurodegenerative diseases like dementia with Lewy bodies.
United States of America
CRVO
Chabiotech Co.,Ltd. Logo
Develops cell/gene therapies and offers CDMO, biobanking, and genomics services for rare diseases.
South Korea
085660
CHAMPIONS ONCOLOGY, INC. Logo
Oncology CRO accelerating drug development with PDX models and multi-omic data analytics.
United States of America
CSBR
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Logo
Global CRO for pharma & biotech, offering research models, safety testing & manufacturing solutions.
United States of America
CRL
Chiome Bioscience Inc. Logo
Clinical-stage biotech developing therapeutic antibodies and providing R&D services to partners.
Japan
4583
Chordate Medical Holding AB Logo
Develops drug-free neuromodulation tech for chronic migraine & rhinitis in the EU & Middle East.
Sweden
CMH
Chordia Therapeutics,Inc Logo
Developing first-in-class, small-molecule anti-cancer drugs targeting RNA deregulation.
Japan
190A
Cibus, Inc. Logo
Develops & licenses gene-edited, non-transgenic traits to the seed industry for resilient crops.
United States of America
CBUS

Talk to a Data Expert

Have a question? We'll get back to you promptly.